Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2014

01.03.2014 | Editorial

The new risk variant CACNA1C and brain circuits in schizophrenia

verfasst von: Andrea Schmitt, Peter Falkai

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Excerpt

In recent genome-wide association studies of severe psychiatric disorders, several risk genes have been detected, but their neurobiological function is widely unknown. A polymorphism in the gene encoding the alpha-1C subunit of the L-type voltage-gated calcium channel (CACNA1C) has been associated with schizophrenia and bipolar disorder and may have impact on structure and function of the amygdala. Wolf et al. [1] investigated the influence of the SNP rs1006737 in CACNA1C on gray matter volumes of the amygdala in patients with schizophrenia, bipolar disorder and obsessive compulsive disorder (OCD). The risk genotype had significant effect on the relative amygdala volume in patients with schizophrenia, while this group and bipolar patients had a smaller left amygdala compared to controls. This supports the hypothesis of disturbed calcium metabolism as a neurobiological background of affective symptoms in schizophrenia. However, CACNA1C is also known to be involved in learning and memory. In a functional MRI study of two independent samples of healthy probands, Krug et al. [2] investigated the impact of rs1006737 on episodic memory encoding and retrieval in the right hippocampus. In both samples, they replicated that in the retrieval condition, carriers of the minor allele (A) had lower activations than G/G allele carriers, thus strengthening the hypothesis that this risk genotype is associated with dysfunction of hippocampus-related memory processes. …
Literatur
1.
Zurück zum Zitat Wolf C, Mohr H, Schneider-Axmann T, Reif A, Wobrock T, Scherk H, Gruber O (2013) CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0427-y Wolf C, Mohr H, Schneider-Axmann T, Reif A, Wobrock T, Scherk H, Gruber O (2013) CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0427-y
2.
Zurück zum Zitat Krug A, Witt SH, Backes H, Dietsche B, Nieratschker V, Shah NJ, Kircher T (2013) A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0428-x Krug A, Witt SH, Backes H, Dietsche B, Nieratschker V, Shah NJ, Kircher T (2013) A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0428-x
3.
Zurück zum Zitat Klingner CM, Kerstin L, Maren D, Stefan S, Otto WW, Heinrich S, Igor N (2013) Thalamocortical connectivity during resting state in schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0417-0 Klingner CM, Kerstin L, Maren D, Stefan S, Otto WW, Heinrich S, Igor N (2013) Thalamocortical connectivity during resting state in schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0417-0
4.
Zurück zum Zitat Xu H, Hong-Ju Y, Xin-Min L (2013) Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0414-3 Xu H, Hong-Ju Y, Xin-Min L (2013) Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0414-3
5.
Zurück zum Zitat Grohmann RR, Engel R, Möller H-J, Rüther E, van der Velden JW, Stübner S (2013) Flupentixol use and adverse reactions in comparison with other common first-and second-generation antipsychotics: data from the AMSP study. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0419-y Grohmann RR, Engel R, Möller H-J, Rüther E, van der Velden JW, Stübner S (2013) Flupentixol use and adverse reactions in comparison with other common first-and second-generation antipsychotics: data from the AMSP study. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0419-y
6.
Zurück zum Zitat Sass K, Stefan H, Olga S, Benjamin S, Frank S, Ute H, T Kircher (2013) Neural correlates of semantic associations in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0425-0 Sass K, Stefan H, Olga S, Benjamin S, Frank S, Ute H, T Kircher (2013) Neural correlates of semantic associations in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0425-0
7.
Zurück zum Zitat Raballo A, Anna M, Angelo C, Davide S, Marco BLR, Andrea A, Maria TC, Antonio P, Kurt M, Heinz H (2013) Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0421-4 Raballo A, Anna M, Angelo C, Davide S, Marco BLR, Andrea A, Maria TC, Antonio P, Kurt M, Heinz H (2013) Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0421-4
8.
Zurück zum Zitat Llorca P-M, Christophe L, Olivier B, Ingrid de C, Ludovic S, Hervé C, Jean-Alexandre L, Franck JB (2013) A composite scale applied to evaluate anxiety in schizophrenic patients (SAES). Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0416-1 Llorca P-M, Christophe L, Olivier B, Ingrid de C, Ludovic S, Hervé C, Jean-Alexandre L, Franck JB (2013) A composite scale applied to evaluate anxiety in schizophrenic patients (SAES). Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0416-1
9.
Zurück zum Zitat Fond G, Alexandra M, Ryad T, Nora H, Alexandre M, Marion L, Jean-Francois D (2013) Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0413-4 Fond G, Alexandra M, Ryad T, Nora H, Alexandre M, Marion L, Jean-Francois D (2013) Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0413-4
Metadaten
Titel
The new risk variant CACNA1C and brain circuits in schizophrenia
verfasst von
Andrea Schmitt
Peter Falkai
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2014
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-014-0487-7

Weitere Artikel der Ausgabe 2/2014

European Archives of Psychiatry and Clinical Neuroscience 2/2014 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.